{"id":"W2611645469","doi":"10.1016/s2352-3026(17)30078-9","title":"Efficacy and safety of subcutaneous rituximab versus intravenous rituximab for first-line treatment of follicular lymphoma (SABRINA): a randomised, open-label, phase 3 trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"European Commission; F. Hoffmann-La Roche","keywords":"Medicine; Rituximab; Follicular lymphoma; Vincristine; Internal medicine; Prednisone; International Prognostic Index; Clinical endpoint; Surgery; Cyclophosphamide; Lymphoma; Oncology; Chemotherapy; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002561139,0.001997415,0.003917253,0.0004914182,0.0005585479,0.001840163,0.001373278,0.002980884,0.006419018],"category_scores_gemma":[0.003090638,0.0009235035,0.002947645,0.0004678858,0.002213143,0.00169777,0.0006184953,0.004500599,0.001525128],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001268253,"about_ca_system_score_gemma":0.001097007,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009935531,"about_ca_topic_score_gemma":0.001169291,"domain_scores_codex":[0.9986243,0.0008113988,0.00006476232,0.000226651,0.00008677595,0.0001861256],"domain_scores_gemma":[0.9980562,0.0007842846,0.0004026925,0.0001954266,0.00009387857,0.0004675138],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9872648,0.003038016,0.0002761376,0.000273146,0.0006743278,0.00002174871,0.00005195443,0.0001779515,0.00102511,0.00005791388,0.000240401,0.006898554],"study_design_scores_gemma":[0.9472095,0.05076552,0.0007378465,0.00002520154,0.0003510161,0.00002998894,0.00002037266,0.0002705305,0.0001986484,0.0001399375,0.0002385667,0.00001279734],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905172,0.004429663,0.0005509328,0.0005572131,0.0004825636,0.001539624,0.0004736948,0.0001024532,0.001346706],"genre_scores_gemma":[0.9931325,0.001438609,0.0008301046,0.0006745536,0.0003546659,0.001675969,0.0004673388,0.00002559229,0.001400566],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006419018,"threshold_uncertainty_score":0.02147382,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09747788966554995,"score_gpt":0.3848782168562778,"score_spread":0.2874003271907279,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}